crystalline forms, saxagliptin chloridate, pharmaceutic composition, process for preparing the i-s form of chloridate and saxagliotin, process for preparing the ht form of saxagliptin chloridate use of crystalline sexagliptin and use of the iv s form of saxagloptine chloridate
ARTHUR PICHLER,CHRISTOPH LANGES,JOSEF WIESER,MILICA VUKICEVIC
申请号：
BRPI1006547
公开号：
BRPI1006547A2
申请日:
2010.04.09
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention relates to novel polymorphic forms of Saxagliptin Hydrochloride. The present invention also relates to methods of making polymorphic forms of Saxagliptin Hydrochloride.
